Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 AUG 10 ... Alkermes, Alnylam Pharmaceuticals, Cubist Pharmaceuticals, Momenta Pharmaceuticals and SirtrisPharmaceuticals. We are pleased to have support from these leading venture capital ...
2009 JAN 26 ... in the healthcare practice, he has been actively involved with BVP's investments in SirtrisPharmaceuticals, acquired by GlaxoSmithKline, Affymax, Oxagen, Aveo Pharmaceuticals, ... companies.
Keywords: Bessemer Venture Partners, EPIX Pharmaceuticals Inc., GlaxoSmithKline, Isis Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical ...
2009 OCT 12 ... is being organized by Christoph Westphal, M.D., Ph.D., Chief Executive Officer of Sirtris, a GSK company and Senior Vice President of the Center of Excellence for External Drug ... Biotechnology, Drug Delivery, Drug Development, Drugs, Medical Device, Pharmaceuticals, Therapies, Therapy, Transdermal, Treatment, BioChemics Inc. This article ...
2009 NOV 2 ... is being organized by Christoph Westphal, M.D., Ph.D., Chief Executive Officer of Sirtris, a GSK company and Senior Vice President of the Center of Excellence for External Drug ... Concert Pharmaceuticals, Inc. announced that it will be presenting at the 2009 Boston Biotech R&D Conference ...
2009 MAR 23 ... component of our strategy at aTyr," said Dr. Schimmel. "Similar to our efforts at Sirtris Pharma, which was sold to Glaxo Smith Kline for $720M in 2008, we will leverage ... Iressa, Merck & Company Inc., Pfizer, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Protein Therapies, Proteomics, Rosuvastatin Calcium, Therapy, Treatment, Virology, aTyr ...
2009 JUN 1 ... are the latest additions to GSK’s RapidFire arsenal, with one system already in use at SirtrisPharmaceuticals, acquired by GSK in 2008, in Cambridge, MA.
“With a ... BioTrove, Inc. announced the sale of two RapidFire® Mass Spectrometry (RF-MS) systems to ...
2009 JAN 19 ... Dr. Thomas Salzmann, former EVP of Preclinical Development at Merck, and Board member at Sirtris and Concert Pharmaceuticals; Dr. Bennett Shapiro, PureTech Senior Partner and former EVP ... financing. InterWest Partners, Prospect Venture Partners, and New Enterprise Associates, Inc. (NEA) co-led the round. The company's founders, PureTech Ventures, and other ...
2009 JUN 22 ... has also been the co-founder of numerous successful biotechnology companies, including SirtrisPharmaceuticals, Alnylam, Repligen, Momenta Pharmaceuticals and Cubist ...
2009 SEP 14 ... of the Board and former EVP of Preclinical Development at Merck, and Board member at Sirtris and Concert Pharmaceuticals; Mr. Chris Ehrlich, General Partner at InterWest Partners; ... and life sciences. He is a member of the Board of Directors of Anadys Pharmaceuticals, Inc. and of the Biotechnology Industry Organization (BIO), and a Trustee of the Berklee ...
2009 MAR 16 ... dedication has resulted in strong exits as demonstrated by Pharmasset, Sirna and Sirtris in 2007 and 2008.”
With the more reasoned company valuations of the ... under management is one of the largest venture and growth investors in biotechnology and pharmaceuticals in Europe and the US, with a growing presence in Asia. The Life Sciences team builds on ... Company, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Pharmasset Inc., TVM Capital.
This article was prepared by Biotech Business Week editors ...
2008 NOV 17 ... in certain target tissues.
The new chemical entity was developed by Sirtris, a a GSK company, and the research study was led by EPFL professor Johan Auwerx, MD.
... Metabolic Disease, Metabolic Disorders, Metabolism, Obesity, Obesity and Diabetes, Pharmaceuticals, Pharmacological, Ecole Polytechnique Federale de Lausanne.
This article ...
2008 NOV 17 ... Alnara's Board of Directors is chaired by Richard Aldrich, co-founder of Vertex and Sirtris, and includes Christoph Westphal, M.D., Ph.D., chief executive officer of Sirtris, a GSK ... Alnara Pharmaceuticals, Inc., a pharmaceutical company developing innovative non-systemic protein therapeutics ...
2008 NOV 17 ... the more potent and specific SIRT1-activating compound SRT1720 developed by the company SirtrisPharmaceuticals, Inc.
The researchers found that a low dose of SRT1720 ...
2008 OCT 28 ... SiOnyx joins a growing list of Harvard spinouts, including Nano-Terra, SiEnergy, and SirtrisPharmaceuticals (NASDAQ: SIRT). Since 2005, more than twenty companies have spun out of ... Harvard University's Office of Technology Development (OTD) and SiOnyx, Inc. announced that SiOnyx has exclusively licensed Harvard's portfolio of black silicon ...
2008 SEP 29 ... Sirtris, a GSK Company focused on discovering and developing small molecule drugs to treat ... 5, 2008, GlaxoSmithKline plc successfully completed the planned acquisition of Sirtris Pharmaceuticals. For more information, visit www.sirtrispharma.com
Keywords: Aging, ...
2008 JUN 16 ... Dependent Diabetes Mellitus, Pharmaceuticals, Therapies, Type 2 Diabetes Mellitus, Sirtris Pharmaceuticals Inc.
This article was prepared by Biotech Business Week editors from staff ...
2008 OCT 6 ... company, GlaxoSmithKline (GSK) is to purchase US-based biotechnology company Sirtris for US$720mn. GSK is to pay US$22.50 a share for the company, 84% above the closing ... has announced the addition of the "United States Pharmaceuticals and Healthcare Report Q3 2008" report to their offering.
Our United ...
2008 SEP 29 ... to DIREVO and Jerini, the TVM Capital Life Science portfolio successfully exited from SirtrisPharmaceuticals, acquired by GlaxoSmithKline, and Pharmasset (the best performing NASDAQ ... Device, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Pharmasset Inc., Pre-Trials Research, Protease, Protein Engineering, Proteomics, Therapies, Therapy, ...
